One-Year Outcomes of Acute Decompensated Systolic Heart Failure in Taiwan: Lessons from TSOC-HFrEF Registry.
暂无分享,去创建一个
Yen-Wen Wu | W. Voon | Wei-Shiang Lin | Chih-Hsin Hsu | Hung-Yu Chang | Kuan-Cheng Chang | W. Tseng | Jiunn-lee Lin | W. Yin | M. Wen | Chun-Chieh Wang | P. Chu | S. Sung | N. Yang | K. Shyu | Heng-Chia Chang | W. Cherng | Chih-Cheng Wu | Ji-Hung Wang | Zhih-Cherng Chen | J. Kuo | Kuei-Chuan Chan | Jin‐Long Huang | S. Chen | G. Mar | Shyh-Ming Chen | Jin-Long Huang | Hung-Yu Chang | Kuei‐Chuan Chan
[1] Gerasimos S Filippatos,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.
[2] C. Lau,et al. Clinical Characteristics, Management, and Outcomes of Hospitalized Heart Failure in a Chinese Population-The Hong Kong Heart Failure Registry. , 2016, Journal of cardiac failure.
[3] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[4] Yen-Wen Wu,et al. TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management. , 2016, Acta Cardiologica Sinica.
[5] A. Tsapas,et al. Empagliflozin , Cardiovascular Outcomes , and Mortality in Type 2 Diabetes , 2015 .
[6] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[7] C. Cannon,et al. Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes , 2015, Diabetes, obesity & metabolism.
[8] J. Wang,et al. Effect of multidisciplinary disease management for hospitalized heart failure under a national health insurance programme , 2015, Journal of cardiovascular medicine.
[9] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.
[10] L. Tavazzi,et al. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. , 2014, International journal of cardiology.
[11] Naoki Sato,et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.
[12] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[13] J. McMurray,et al. Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations , 2012, Circulation.
[14] M. Cho,et al. Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[15] Chau-Chung Wu,et al. 2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the diagnosis and treatment of heart failure , 2012 .
[16] Wen-Chung Yu,et al. Guidelines of the Taiwan Society of Cardiology ( TSOC ) for the Diagnosis and Treatment of Heart Failure , 2012 .
[17] J. McMurray,et al. Eplerenone in patients with systolic heart failure and mild symptoms. , 2011, The New England journal of medicine.
[18] Ankur Gupta,et al. Ivabradine and outcomes in chronic heart failure , 2010, The Lancet.
[19] Inger Ekman,et al. Population Impact of Heart Failure and the Most Common Forms of Cancer: A Study of 1 162 309 Hospital Cases in Sweden (1988 to 2004) , 2010, Circulation. Cardiovascular quality and outcomes.
[20] Piotr Ponikowski,et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure , 2010, European journal of heart failure.
[21] A. Takeshita,et al. Characteristics and Outcomes of Hospitalized Patients With Heart Failure and Reduced vs Preserved Ejection Fraction , 2009 .
[22] Colin Simpson,et al. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People , 2009, Circulation.
[23] E. Ferenczi,et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure , 2008, Heart.
[24] Masahiro Ito,et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[25] A. Hoes,et al. Clinical epidemiology of heart failure , 2007, Heart.
[26] Nancy M Albert,et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.
[27] K. Chien,et al. Impact of heart failure and left ventricular function on long‐term survival — Report of a community‐based cohort study in Taiwan , 2007, European journal of heart failure.
[28] C. Yancy,et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). , 2007, American heart journal.
[29] W. Frishman,et al. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure , 2007 .
[30] F. Rodríguez‐Artalejo,et al. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. , 2004, European heart journal.
[31] K. Swedberg,et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. , 2004, European heart journal.
[32] Daniel Levy,et al. Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.
[33] D. DeMets,et al. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.
[34] J. Cohn,et al. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. , 2002, Journal of the American College of Cardiology.
[35] S Capewell,et al. More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure , 2001, European journal of heart failure.
[36] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[37] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[38] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[39] R. Carney,et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.
[40] G. Bonsel,et al. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. , 1994, American journal of public health.
[41] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[42] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[43] K. White,et al. Clinical epidemiology. , 1983, International journal of epidemiology.